Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacteriophage-mediated lysis is the regulated process by which bacteriophages (viruses that infect bacteria) destroy their bacterial host cells to release progeny virions. This process typically involves a coordinated action of several bacteriophage-encoded proteins: holins (which create lesions in the bacterial membrane), endolysins (which enzymatically degrade the bacterial cell wall), and often spanins (which facilitate the final disruption of the cell envelope in Gram-negative bacteria). Alternate lysis mechanisms exist, often involving single-membrane proteins that trigger endogenous bacterial autolysins. This lysis is essential both for the phage life cycle and, in clinical or biotech contexts, may be leveraged for antibacterial therapies or for controlled release of cellular contents
Bacterial cell wall degradation via endolysins - Pore formation in the bacterial membrane via holins - Membrane fusion via spanins - In some phages, activation of bacterial autolysins by single membrane proteins (e.g., protein E of φX174)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacteriophage lysis system.